Suchergebnisse - "Kahn, Steven E"

PubPharm (539)

1

Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes : A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy

enthalten in: Diabetes care | 2024

von Utzschneider, K. | Younes, N. | Butera, N. | +112

2

Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes : The GRADE Randomized Clinical Trial

enthalten in: Diabetes care | 2024

von Rasouli, N. | Younes, N. | Ghosh, A. | +112

3

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure

enthalten in: Diabetes care | 2024

von Lee, C. | Ciarleglio, A. | Edelstein, S. | +109

4

RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes

enthalten in: Molecular metabolism | 2024

von Mukherjee, N. | Contreras, C. | Lin, L. | +6

5

Human islet amyloid polypeptide-induced β-cell cytotoxicity is linked to formation of α-sheet structure

enthalten in: Protein science : a publication of the Protein Society | 2024

von Hsu, C. | Templin, A. | Prosswimmer, T. | +5

6

GAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study

enthalten in: Journal of the Endocrine Society | 2024

von Hampe, C. | Shojaie, A. | Brooks-Worrell, B. | +15

ErratumIn: J Endocr Soc. 2024 Apr 01;8(5):bvae058. - PMID 38562128

7

Reflecting on a Year at the Helm of Diabetes Care

enthalten in: Diabetes care | 2024

von Kahn, S. | Anderson, C. | Buse, J. | +29

8

Daniel Porte Jr., 13 August 1931-13 May 2023

enthalten in: Diabetes | 2024

von Kahn, S. | Woods, S. | Halter, J. | +2

9

Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure

enthalten in: Protein Science | 2024

von Hsu, C. | Templin, A. | Prosswimmer, T. | +5

10

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease : SURPASS-CVOT design and baseline characteristics

enthalten in: American heart journal | 2024

von Nicholls, S. | Bhatt, D. | Buse, J. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[54]